Astaxanthin, a reddish-orange pigment from microalgae that accumulates in salmon, prawns and flamingos, is widely marketed as a supplement for skin, vision, memory, joints, athletic performance and anti-ageing. The evidence supporting these claims varies considerably.
The strongest data comes from skin health. A review of 11 studies found astaxanthin improved skin moisture and elasticity compared with placebo, though the benefits were largely seen in healthy women and did not show clear reductions in wrinkle depth. Most trials were small and short, making it unclear whether improvements last or are visible to the naked eye.
For exercise recovery, a review of 24 trials found astaxanthin reduced markers of muscle damage after exercise. However, there was no clear improvement in aerobic fitness, maximum power or time-trial performance. Blood markers do not necessarily translate into less soreness or faster return to training.
Cognitive evidence is weaker. An analysis of 11 trials involving 346 healthy participants found no clear improvement in reaction time and only marginal effects on cognitive accuracy, falling far short of claims about dementia or age-related decline protection.
Claims about eyesight and heart health rest largely on plausible biological mechanisms but limited and inconsistent evidence. Some human studies reported improvements in cholesterol and blood sugar, but improving one measurement does not prove a supplement prevents heart attacks or strokes.
An analysis of nine clinical trials found no significant effect on body weight or body mass index for weight loss claims.
The European Food Safety Authority concluded 8mg daily from supplements alongside dietary sources was safe for adults. Short-term side-effects are usually mild and include stomach discomfort and stool colour changes. Very high intakes may tint skin reddish. Long-term safety remains unknown, as does safety for children and during pregnancy and breastfeeding.
Mayur Ranchordas, Professor of Applied Sport Nutrition at Sheffield Hallam University, notes that until larger independent trials provide stronger answers, the most noticeable effect may be financial impact on users.